Login / Signup
ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets.
Yuehong Chen
Huan Liu
Zhongling Luo
Jiaqian Zhang
Min Dong
Geng Yin
Qibing Xie
Published in:
Skeletal muscle (2024)
ASM is involved in the pathology of DM by regulating the differentiation of naive CD4 + T cells and can be a potential treatment target.
Keyphrases
</>
hiv infected
disease activity
human health
systemic lupus erythematosus
antiretroviral therapy
systemic sclerosis
weight loss
glycemic control